Phase II trial of DS102 in chronic obstructive pulmonary disease (COPD) patients.

Trial Profile

Phase II trial of DS102 in chronic obstructive pulmonary disease (COPD) patients.

Planning
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2017

At a glance

  • Drugs DS 102 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 20 Oct 2017 According to an Afimmune media release, the company expects to initiate this trial soon and data read out is expected towards the end of 2018.
    • 30 May 2016 New trial record
    • 23 May 2016 According to DS Biopharma media release, the company will start this trial later this year.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top